Crotalidae polyvalent immune Fab
Crotalidae Polyvalent Immune Fab (Ovine) (CroFab) is a pharmaceutical drug used in the treatment of envenomations by North American crotalids, including rattlesnakes, copperheads, and cottonmouth/water moccasins. It is a type of antivenom that is derived from the immune response of sheep to the venom of these snakes. The product is a mixture of Fab fragments of immunoglobulin G (IgG), making it less likely to cause allergic reactions and serum sickness compared to older, whole-antibody antivenom preparations.
History[edit | edit source]
The development of Crotalidae Polyvalent Immune Fab (Ovine) marked a significant advancement in the treatment of venomous snake bites in North America. Prior to its introduction, treatments involved the use of whole IgG antivenoms, which were associated with a higher risk of adverse reactions. CroFab was approved by the Food and Drug Administration (FDA) in the United States in 2000, offering a safer alternative for patients.
Mechanism of Action[edit | edit source]
CroFab works by binding to the venom toxins of crotalid snakes, neutralizing their effects and facilitating their removal from the body. The Fab fragments are specifically designed to target and bind to the venom proteins, preventing them from causing damage to the body. This action reduces the severity of the envenomation and promotes recovery.
Indications[edit | edit source]
Crotalidae Polyvalent Immune Fab (Ovine) is indicated for the management of adult and pediatric patients with North American crotalid envenomation. The severity of the snake bite and the clinical symptoms of the patient determine the necessity and the dosage of the antivenom.
Administration[edit | edit source]
The administration of CroFab should be initiated as soon as possible after the snake bite to ensure the best possible outcome. The initial dose and subsequent doses are based on the clinical response of the patient. Continuous monitoring of the patient is necessary to adjust the treatment as needed.
Side Effects[edit | edit source]
While CroFab is generally well-tolerated, some patients may experience adverse reactions. Common side effects include rash, pruritus (itching), nausea, and back pain. Severe allergic reactions are rare but can occur, especially in individuals with known allergies to sheep proteins.
[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD